Skip to content
stoqly

Crown

CCK NYSE Paper & Plastic Packaging Products & Materials Financials FY2016–FY2025

Crown's revenue rose 4.8% to $12.4 billion in fiscal 2025. Its operating margin was 12.6%, up from 12.0% a year earlier. Free cash flow was $1.1 billion, up 41.6%. It paid out $625 million in dividends and buybacks, 56% of free cash flow. The diluted share count fell 3.1%.

Last close Β· Oct 23, 2026

$117.29

1.7%
Revenue Total sales reported in the income statement.
$12.4B
4.8% vs prior year
Operating margin Operating income as a share of revenue.
12.6%
0.5 pts
Net income Profit after all expenses, interest and tax.
$738M
74.1%
Free cash flow Cash from operations minus capital spending.
$1.1B
41.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
13.7%
1.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$12.9B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
16.9x
On $6.96 EPS (TTM)

What Crown does

No business description yet.

Legal name
CROWN HOLDINGS, INC.
Fiscal year ends
December 31, 2025
Latest annual report
β€”
Accession Β· CIK
0001628280-26-012904
0001219601

Revenue and margins

Crown had $12.4B of revenue in fiscal 2025, up 4.8% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 6.7% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $1.1B in fiscal 2025, 9.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Crown returned $625M to shareholders in fiscal 2025, 56% of free cash flow. The diluted share count fell 3.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Crown yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$5.2B and divides by 115.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 16.9x Β· peers 16.6x Β· sector 20.6x.

Balance sheet

Cash, debt and the ratios that show how comfortably Crown can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $531M$550M$1.3B$918M$764M
Debt incl. finance leases $6.3B$7.0B$7.5B$6.2B$6.0B
Net debt / EBITDA β€”3.6x3.5x2.8x2.6x
Debt / equity 3.3x3.8x3.1x2.3x2.0x
Interest coverage 5.4x4.7x2.9x3.1x3.9x
Current ratio 1.1x1.2x1.2x1.2x1.0x
Quick ratio 0.7x0.7x0.8x0.8x0.7x
Total assets $13.9B$14.3B$15.0B$13.8B$14.3B
Total liabilities $11.5B$12.0B$12.2B$10.6B$10.8B
Shareholders' equity $1.9B$1.8B$2.4B$2.8B$3.0B
Net debt (βˆ’ = net cash) $5.7B$6.4B$6.2B$5.3B$5.2B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$16.5M

3 insiders

Of sales under plans

58%

$9.5M

DateInsiderTradeSharesPriceValueFiling
Jul 15, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 7,500 $110.29 $0.8M Form 4
Jun 23, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 15,000 $105.00 $1.6M Form 4
Apr 15, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 7,500 $106.85 $0.8M Form 4
Apr 8, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 7,500 $105.00 $0.8M Form 4
Feb 23, 2026 Djalma Novaes JrEVP & COO Sold 29,734 $114.80 $3.4M Form 4
Feb 20, 2026 Gerard H GiffordEVP & CAO Sold 13,373 $113.98 $1.5M Form 4
Feb 18, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 7,500 $110.67 $0.8M Form 4
Jan 29, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 7,500 $105.00 $0.8M Form 4
Jan 5, 2026 Timothy J DonahuePresident & CEO, Director Sold plan 29,024 $105.00 $3.0M Form 4
Dec 18, 2025 Timothy J DonahuePresident & CEO, Director Sold plan 8,476 $105.01 $0.9M Form 4
Dec 16, 2025 Djalma Novaes JrEVP & COO Sold 19,754 $101.02 $2.0M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ• βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ“ βœ“
Current ratio rose βœ• βœ“ βœ•
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose β€” β€” β€”
Revenue rose relative to assets βœ• βœ• βœ“
F-score 4 / 86 / 87 / 8
Accruals ratio βˆ’6.8%βˆ’5.3%βˆ’5.6%
Altman Z'' 1.842.212.00

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Crown CCK $12.9B 4.8% 12.6% 9.0% 13.7% 16.9x 7
Packaging Corporation of America PKG $22.0B 7.2% 12.3% 8.1% 11.8% 32.1x 4 Compare β†’
Avery Dennison AVY $13.9B 1.1% β€” 8.0% 14.6% 19.9x 5 Compare β†’
Graphic Packaging GPK $2.6B βˆ’2.2% 9.3% βˆ’0.9% 7.3% 13.3x 4 Compare β†’
Sonoco SON $5.0B 41.7% 13.5% 4.6% 9.4% 4.9x 5 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $8.3B $8.7B $11.2B $11.7B $9.4B $11.4B $12.9B $12.0B $11.8B $12.4B
Research and development $41.0M $39.0M $51.0M $50.0M $48.0M $47.0M $34.0M $33.0M $32.0M $33.0M
Operating income $997M $1.0B $1.1B $1.0B $1.0B $1.4B $1.3B $1.3B $1.4B $1.6B
Interest expense $243M $252M $384M $367M $290M $253M $284M $436M $452M $398M
Pretax income $769M $829M $740M $631M $725M βˆ’$419M $1.1B $795M $743M $1.2B
Income tax $186M $401M $216M $136M $199M βˆ’$57.0M $243M $222M $183M $281M
Net income $496M $323M $439M $510M $579M βˆ’$560M $727M $450M $424M $738M
Diluted EPS $3.56 $2.38 $3.28 $3.78 $4.30 βˆ’$4.30 $5.99 $3.76 $3.55 $6.38
Diluted shares 0.14B 0.14B 0.13B 0.13B 0.13B 0.13B 0.12B 0.12B 0.12B 0.12B
Cash flow
Cash from operations βˆ’$134M βˆ’$251M $571M $1.2B $1.3B $905M $803M $1.5B $1.2B $1.5B
Capital expenditure $473M $498M $462M $391M $554M $816M $839M $793M $403M $413M
Free cash flow βˆ’$607M βˆ’$749M $109M $772M $761M $89.0M βˆ’$36.0M $660M $789M $1.1B
Depreciation and amortization β€” β€” β€” β€” β€” β€” $460M $499M $448M $456M
Stock-based compensation $20.0M $23.0M $27.0M $29.0M $32.0M $33.0M $29.0M $31.0M $42.0M $48.0M
Acquisitions $0.0M $0.0M $3.9B $11.0M $0.0M $0.0M $31.0M $126M $0.0M $0.0M
Share buybacks $8.0M $339M $4.0M $7.0M $66.0M $950M $722M $12.0M $217M $505M
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $105M $106M $115M $119M $120M
Dividends and buybacks $8.0M $339M $4.0M $7.0M $66.0M $1.1B $828M $127M $336M $625M
Balance sheet
Cash and short-term investments $559M $424M $607M $607M $1.2B $531M $550M $1.3B $918M $764M
Total debt $4.9B $5.3B $8.7B $8.0B $8.2B $6.3B $7.0B $7.5B $6.2B $6.0B
Finance lease liabilities $0.0M $0.0M $0.0M $13.0M $12.0M $10.0M $7.0M $6.0M $4.0M $4.0M
Current assets $2.8B $3.1B $4.1B $4.0B $4.9B $4.5B $4.7B $4.8B $4.2B $4.4B
Current liabilities $2.9B $3.3B $3.9B $3.9B $4.3B $4.1B $3.9B $4.2B $3.5B $4.3B
Inventory $1.2B $1.4B $1.7B $1.6B $1.3B $1.7B $2.0B $1.6B $1.4B $1.6B
Property and equipment, net $2.8B $3.2B $3.7B $3.9B $3.7B $4.0B $4.5B $5.1B $4.9B $5.2B
Total assets $9.6B $10.7B $15.3B $12.7B $16.7B $13.9B $14.3B $15.0B $13.8B $14.3B
Total liabilities $8.9B $9.7B $14.0B $13.4B $14.1B $11.5B $12.0B $12.2B $10.6B $10.8B
Shareholders' equity $366M $601M $937M $1.7B $2.2B $1.9B $1.8B $2.4B $2.8B $3.0B
Margins
Operating margin 12.0% 11.8% 9.8% 8.8% 11.2% 12.0% 10.3% 10.6% 12.0% 12.6%
EBITDA margin β€” β€” β€” β€” β€” β€” 13.9% 14.7% 15.8% 16.3%
Net margin 6.0% 3.7% 3.9% 4.4% 6.2% βˆ’4.9% 5.6% 3.8% 3.6% 6.0%
FCF margin βˆ’7.3% βˆ’8.6% 1.0% 6.6% 8.1% 0.8% βˆ’0.3% 5.5% 6.7% 9.0%
Returns
Return on capital 14.8% 9.7% 10.2% 8.6% 8.0% 12.2% 12.3% 10.3% 12.2% 13.7%
Return on capital employed 14.4% 14.5% 11.7% 10.2% 9.9% 12.3% 13.3% 12.0% 13.4% 15.2%
Return on equity β€” β€” 57.1% 38.5% 29.6% βˆ’27.3% 38.7% 21.1% 16.4% 25.7%
Return on assets 5.1% 3.2% 3.4% 3.7% 3.9% βˆ’3.7% 5.2% 3.1% 2.9% 5.3%
Growth
Revenue growth βˆ’5.5% 5.0% 28.2% 4.6% βˆ’19.5% 21.3% 13.6% βˆ’7.2% βˆ’1.7% 4.8%
Net income growth 26.2% βˆ’34.9% 35.9% 16.2% 13.5% βˆ’196.7% β€” βˆ’38.1% βˆ’5.8% 74.1%
EPS growth 26.2% βˆ’33.2% 37.8% 15.2% 13.8% βˆ’200.0% β€” βˆ’37.2% βˆ’5.6% 79.7%
FCF growth βˆ’200.8% β€” β€” 608.3% βˆ’1.4% βˆ’88.3% βˆ’140.5% β€” 19.6% 41.6%
Share count change 0.1% βˆ’2.7% βˆ’1.3% 0.8% βˆ’0.2% βˆ’3.1% βˆ’6.9% βˆ’1.4% βˆ’0.2% βˆ’3.1%
Financial health
Net debt / EBITDA β€” β€” β€” β€” β€” β€” 3.6x 3.5x 2.8x 2.6x
Debt / equity β€” 8.9x 9.3x 4.7x 3.7x 3.3x 3.8x 3.1x 2.3x 2.0x
Interest coverage 4.1x 4.1x 2.9x 2.8x 3.6x 5.4x 4.7x 2.9x 3.1x 3.9x
Current ratio 1.0x 1.0x 1.0x 1.0x 1.2x 1.1x 1.2x 1.2x 1.2x 1.0x
Quick ratio 0.6x 0.5x 0.6x 0.6x 0.9x 0.7x 0.7x 0.8x 0.8x 0.7x
Capital allocation
Capex / revenue 5.7% 5.7% 4.1% 3.4% 5.9% 7.2% 6.5% 6.6% 3.4% 3.3%
Stock comp / revenue 0.2% 0.3% 0.2% 0.3% 0.3% 0.3% 0.2% 0.3% 0.4% 0.4%
Payouts / FCF β€” β€” 3.7% 0.9% 8.7% 1,185.4% β€” 19.2% 42.6% 56.0%
Quality scores
Piotroski F-score 3.0 3.0 7.0 4.0 7.0 4.0 7.0 4.0 6.0 7.0
Altman Z'' 1.6 1.6 1.4 1.8 1.8 1.8 1.9 1.8 2.2 2.0
Accruals ratio 6.4% 5.7% βˆ’1.0% βˆ’4.7% βˆ’5.0% βˆ’9.6% βˆ’0.5% βˆ’6.8% βˆ’5.3% βˆ’5.6%

Source: SEC EDGAR XBRL filings (CIK 0001219601). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open